Arthur M. Cohen & Associates, LLC Bluebird Bio, Inc. Transaction History

Arthur M. Cohen & Associates, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 04, 2019	SELL	$59.47 - $93.1 $95,508 - $149,518	-1,606 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$75.84 - $105.21 $121,799 - $168,967	-1,606 Reduced 50.0%	1,606 $205,000
Q1 2019 May 07, 2019	SELL	$64.44 - $104.11 $64 - $104	-1 Reduced 0.03%	3,212 $505,000
Q3 2014 Nov 08, 2017	BUY	N/A	3,213	3,213 $441,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.